Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Genesis Announces $12 Million in New Orders

publication date: Sep 12, 2008

Genesis Pharmaceuticals Enterprises, Inc. reported that it booked $12 million in new orders at the 43rd Annual New Drugs Conference sponsored by China Health Tech Forum 2008. Genesis will deliver the products over the next 12 months to more than 800 wholesale distributors. Genesis also said that more than 60% of the orders were for its newest product, Radix Isatidis Disperable Tablets, a nonprescription TCM treatment for flu. More details...

Stock Symbols: (OTCBB: GNPH)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital